Effects of anti-viral therapy in combination with transcatheter arteria chemoembolization on recurrence of HBVrelated hepatocellular carcinoma after operation
10.3760/cma.j.issn.1007-8118.2010.10.012
- VernacularTitle:抗病毒和肝动脉插管栓塞化疗联合应用对乙肝相关性肝癌术后复发的影响
- Author:
Jun NI
;
Qiang YAN
;
Wenbin YUAN
;
Mingjie ZHANG
;
Guolei ZHANG
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Anti-viral therapy;
TACE;
Recurrence
- From:
Chinese Journal of Hepatobiliary Surgery
2010;16(10):751-753
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the preventive effects of anti-viral therapy in combination with transcatheter arteria chemoembolization (TACE) on recurrence of HBV-related hepatocellular carcinoma (HCC) after operation. Methods According to selection standards, 49 patients treated in this hospital from January 2003 to June 2009 were enrolled in this study and divided into a control group and combined group.The cumulative tumor-free survival rate, cumulative survival rate, the 1-, 2- and 3-year recurrence rates and cumulative recurrence rates were determined in all the patients and compared between the 2 groups. Results The cumulative tumor-free survival rate and cumulative survival rate were significantly higher in the combined group than in the control group (P=0. 019, 0. 008). The 1-, 2-, and 3-recurrence rates were 24% vs. 38.9%, 28% vs. 33.3%, and 28% vs. 22.2% in the combined group and control group, respectively. The 1-, 2-, and 3-year cumulative recurrence rates were 24% vs. 38. 9%, 52% vs. 72. 2%, and 80% vs.94. 4% in the combined group and control group, respectively. Conclusion Anti-viral therapy in combination with TACE can exert significant preventive effects on recurrence of HBV-related HCC after operation.
